MedTrace Logo

Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis

NCT05731596 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2023-05-16

No results posted yet for this study

Summary

This study will be a randomized, controlled, parallel study that aims to evaluate the efficacy and safety of Rosuvastatin versus Coenzyme Q10 on nonalcoholic steatohepatitis patients.

Conditions

Interventions

DRUG

Rosuvastatin 20 Mg Oral Tablet

Rosuvastatin 20 mg will be administered orally once daily for 3 Months

DRUG

Coenzyme Q10 100 MG Oral Capsule

Coenzyme Q10 100 mg will be administered orally once daily for 3 Months

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Hadeer Ahmed Alsayed, B.Sc. Degree · Faculty of pharmacy , Pharos University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-30
Primary Completion
2024-02-29
Completion
2024-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05731596 on ClinicalTrials.gov